Manufacturing

Articles

AuroMedics Pharma issued a voluntary, nationwide recall of two lots of piperacillin and tazobactam for injection, USP 3.375 g due to the presence of particulates identified as glass and silicone material.

AuroMedics Pharma Issues Voluntary Recall Due to Glass and Silicone Particulates

Pfizer will invest nearly half a billion dollars to build a sterile injectable facility in Michigan. 

Pfizer to Build Sterile Injectable Facility in Michigan

The agency has issued a warning letter for cGMP violations at a drug manufacturing facility in Ahmedabad, India, that Baxter gained through its acquisition of Claris Injectables.

FDA Issues Warning Letter to Baxter’s Drug Manufacturing Plant Acquired in Claris Buy

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

Traditional glass and polymeric materials compete for market share in primary packaging for parenteral drug products.

Selecting Primary Packaging for Parenterals

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Automated robotic arms manipulate nested trays and containers inside closed aseptic filling systems.

Robotics Solve Aseptic Filling Challenges

Pharmaceutical machine concepts for large and small factories of the future need to be readily available, flexible when it comes to processing variation, and modular in design. 

Groninger Presents Machine Range for Large and Small Factories at Achema 2018

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Determining the right process conditions for a freeze-drying cycle requires an understanding of the effect of each step on the drug product.

Freeze-Drying Process Optimization

The company is voluntarily recalling three lots of Labetalol Hydrochloride Injection, USP, 100 mg/20 mL Vial and one lot of Labetalol Hydrochloride Injection, USP, Novaplus because of the potential of cracked glass at the rim of the vials.

Hospira Recalls Labetalol Hydrochloride Due to Cracked Vials

The biotechnology company has filed for FDA approval of a new plasma manufacturing facility in Covington, GA, to support its immunology franchise.

Shire Files for FDA Approval of a New Plasma Manufacturing Facility

The company has officially opened a local brand office in South Korean to support its existing business in the region.

Manufacturing, Liquid Drug Products